ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
33
views
0
references
Top references
cited by
113
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,799
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
Author(s):
Hedy L. Kindler
,
Tatsuya Ioka
,
Dirk Richel
,
Jaafar Bennouna
,
Richard Letourneau
,
Takuji Okusaka
,
Akihiro Funakoshi
,
Junji Furuse
,
Young Suk Park
,
Shinichi Ohkawa
,
Gregory M. Springett
,
Harpreet S Wasan
,
Peter Trask
,
Paul Bycott
,
Alejandro D Ricart
,
Sinil Kim
,
Eric Van Cutsem
Publication date:
2011-03-01
Journal:
The Lancet Oncology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Procedural speed in criminal law
Author and article information
Journal
DOI::
10.1016/S1470-2045(11)70004-3
PubMed ID::
21306953
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,799
A randomized, double-blind phase II study of the oral tyrosine kinase inhibitor (TKI) axitinib (AG-013736) in combination with docetaxel (DOC) compared to DOC plus placebo (PL) in metastatic breast cancer (MBC) [abstract 1003]
Authors:
HS Rugo
,
A Stopeck
,
A Joy
…
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma
Authors:
Alan Chan
,
Carolyn Dang
,
Jessica A. Wisniewski
…
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
Authors:
Jiwei Huang
,
Yueming Wang
,
Fan Xu
…
See all similar
Cited by
111
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Authors:
Abdel N. Hosein
,
Rolf A Brekken
,
Anirban Maitra
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Authors:
Michael A Jacobetz
,
Derek Chan
,
Albrecht Neesse
…
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Authors:
Aleksandra Adamska
,
Alice Domenichini
,
Marco Falasca
See all cited by
Version 1
- Current
Version 1